A detailed history of Bailard, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Bailard, Inc. holds 88,876 shares of DHR stock, worth $21.3 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
88,876
Previous 80,770 10.04%
Holding current value
$21.3 Million
Previous $18.7 Million 18.78%
% of portfolio
0.62%
Previous 0.56%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$224.58 - $256.19 $1.82 Million - $2.08 Million
8,106 Added 10.04%
88,876 $22.2 Million
Q4 2023

Feb 02, 2024

SELL
$185.1 - $233.13 $1.37 Million - $1.73 Million
-7,427 Reduced 8.42%
80,770 $18.7 Million
Q3 2023

Oct 24, 2023

BUY
$233.08 - $265.59 $1.96 Million - $2.24 Million
8,420 Added 10.55%
88,197 $21.9 Million
Q2 2023

Jul 20, 2023

BUY
$224.99 - $256.14 $793,539 - $903,405
3,527 Added 4.63%
79,777 $19.1 Million
Q1 2023

May 08, 2023

BUY
$239.75 - $277.0 $288,419 - $333,231
1,203 Added 1.6%
76,250 $19.2 Million
Q4 2022

Feb 02, 2023

BUY
$241.42 - $282.29 $255,663 - $298,945
1,059 Added 1.43%
75,047 $19.9 Million
Q3 2022

Oct 18, 2022

BUY
$247.06 - $1507.4 $457,555 - $2.79 Million
1,852 Added 2.57%
73,988 $19.1 Million
Q2 2022

Jul 27, 2022

SELL
$237.11 - $299.66 $202,729 - $256,209
-855 Reduced 1.17%
72,136 $18.3 Million
Q1 2022

Apr 25, 2022

BUY
$257.27 - $315.76 $407,772 - $500,479
1,585 Added 2.22%
72,991 $21.4 Million
Q4 2021

Feb 10, 2022

BUY
$292.08 - $329.01 $10,514 - $11,844
36 Added 0.05%
71,406 $23.5 Million
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $3.06 Million - $3.73 Million
11,229 Added 18.67%
71,370 $21.7 Million
Q2 2021

Aug 13, 2021

BUY
$225.08 - $271.69 $199,420 - $240,717
886 Added 1.5%
60,141 $16.1 Million
Q1 2021

May 13, 2021

SELL
$212.38 - $245.9 $203,884 - $236,064
-960 Reduced 1.59%
59,255 $13.3 Million
Q4 2020

Feb 03, 2021

SELL
$212.5 - $245.46 $644,300 - $744,234
-3,032 Reduced 4.79%
60,215 $13.4 Million
Q3 2020

Nov 10, 2020

BUY
$177.16 - $215.33 $51,199 - $62,230
289 Added 0.46%
63,247 $13.6 Million
Q2 2020

Aug 12, 2020

BUY
$128.7 - $176.83 $498,841 - $685,393
3,876 Added 6.56%
62,958 $11.1 Million
Q1 2020

Apr 16, 2020

BUY
$121.39 - $169.05 $569,561 - $793,182
4,692 Added 8.63%
59,082 $8.18 Million
Q4 2019

Jan 31, 2020

BUY
$133.47 - $153.48 $1.49 Million - $1.71 Million
11,144 Added 25.77%
54,390 $8.35 Million
Q3 2019

Oct 18, 2019

BUY
$135.4 - $146.47 $270 - $292
2 Added 0.0%
43,246 $6.25 Million
Q2 2019

Jul 26, 2019

SELL
$124.88 - $143.73 $2.41 Million - $2.78 Million
-19,321 Reduced 30.88%
43,244 $6.18 Million
Q1 2019

Apr 24, 2019

SELL
$97.62 - $132.29 $324,684 - $439,996
-3,326 Reduced 5.05%
62,565 $8.26 Million
Q4 2018

Feb 05, 2019

BUY
$94.85 - $109.54 $87,831 - $101,434
926 Added 1.43%
65,891 $6.8 Million
Q3 2018

Nov 13, 2018

SELL
$98.13 - $108.9 $395,660 - $439,084
-4,032 Reduced 5.84%
64,965 $7.06 Million
Q2 2018

Aug 08, 2018

SELL
$96.1 - $103.24 $357,395 - $383,949
-3,719 Reduced 5.11%
68,997 $6.81 Million
Q1 2018

May 07, 2018

SELL
$92.16 - $103.8 $748,892 - $843,478
-8,126 Reduced 10.05%
72,716 $7.12 Million
Q4 2017

Feb 08, 2018

BUY
$85.26 - $94.62 $2.03 Million - $2.25 Million
23,795 Added 41.71%
80,842 $0
Q3 2017

Oct 11, 2017

BUY
$79.29 - $88.45 $342,929 - $382,546
4,325 Added 8.2%
57,047 $4.89 Million
Q2 2017

Aug 11, 2017

BUY
N/A
57 Added 0.11%
52,722 $0
Q1 2017

Jan 29, 2018

BUY
N/A
18,431 Added 53.84%
52,665 $4.5 Million
Q4 2016

Jan 29, 2018

BUY
N/A
7,538 Added 28.24%
34,234 $0
Q3 2016

Jan 29, 2018

BUY
N/A
5,123 Added 23.75%
26,696 $2.09 Million
Q2 2016

Jan 29, 2018

BUY
N/A
14,963 Added 226.37%
21,573 $0
Q1 2016

Jan 29, 2018

BUY
N/A
2,245 Added 51.43%
6,610 $627,000
Q3 2015

Jan 29, 2018

SELL
N/A
-1,000 Reduced 18.64%
4,365 $372,000
Q2 2015

Jan 29, 2018

BUY
N/A
5,365
5,365 $0

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $175B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.